ORTI-A Ortivus AB (publ)

STO · SE · Healthcare · Medical Instruments & Supplies · ortivus.com

1.720SEK+6.17%Mkt Cap: 14.58M $P/E: —Today

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and EC…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap14.58M USD

Enterprise Value16.02M USD

Revenue (TTM)7.31M USD

Gross Profit2.83M USD

Net Income (TTM)-2.09M USD

Revenue/Share1.04 SEK

Last Price1.720 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees32

CountrySE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG4.48

EV/EBITDA-9.18

EV/Revenue2.19

P/S1.88

P/B6.40

EPS (TTM)-0.29

EPS (Forward)—

52W Range

1.30021% of range3.300

52W High3.300 SEK

52W Low1.300 SEK

Profitability

Gross Margin40.33%

Oper. Margin-31.77%

EBITDA Margin-23.87%

Profit Margin-29.80%

ROE-97.60%

ROA-30.84%

Growth

Revenue Growth-1.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.41M USD

CapEx (TTM)917.59K USD

FCF Margin-34.29%

FCF Yield-17.19%

Net Debt2.29M USD

Net Debt/EBITDA-1.31

Balance Sheet

Debt/Equity0.87

Current Ratio1.08

Quick Ratio0.73

Book Value/Sh0.25 SEK

Cash/Share0.08 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.66M

Float9.15M

Insiders47.99%

Institutions2.43%

Technical

SMA 502.071 (-16.9%)

SMA 2002.056 (-16.4%)

Beta0.90

S&P 52W Chg14.58%

Avg Vol (30d)458

Avg Vol (10d)224

Technical Indicators

RSI (14)39.2

MACD-0.0445

MACD Signal-0.0278

MACD Hist.-0.0167

BB Upper2.271 SEK

BB Middle1.971 SEK

BB Lower1.671 SEK

BB Width30.44%

ATR (14)0.1698 SEK

Vol Ratio (20d)0.00x